SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation

NCT01855191 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 864

Last updated 2019-03-26

No results posted yet for this study

Summary

Introducing standardized data collection (SDC) for lung cancer patients to improve the performance of the prediction models.

Conditions

Sponsors & Collaborators

  • Maastricht Radiation Oncology

    lead OTHER

Principal Investigators

  • Dirk De Ruysscher, MD., PhD. · Maastro Clinic, The Netherlands

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01855191 on ClinicalTrials.gov